EP
GSK icon

Eversept Partners’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$86.1M Sell
2,242,388
-380,858
-15% -$14.6M 7.92% 2
2025
Q1
$102M Sell
2,623,246
-1,038,522
-28% -$40.2M 10.32% 2
2024
Q4
$124M Sell
3,661,768
-395,438
-10% -$13.4M 10.99% 2
2024
Q3
$166M Buy
4,057,206
+589,126
+17% +$24.1M 11.36% 1
2024
Q2
$134M Sell
3,468,080
-303,914
-8% -$11.7M 9.14% 1
2024
Q1
$162M Buy
3,771,994
+799,040
+27% +$34.3M 10.79% 2
2023
Q4
$110M Sell
2,972,954
-286,388
-9% -$10.6M 9.68% 2
2023
Q3
$118M Buy
3,259,342
+378,330
+13% +$13.7M 10% 1
2023
Q2
$104M Sell
2,881,012
-850,487
-23% -$30.6M 8.68% 2
2023
Q1
$134M Buy
3,731,499
+241,042
+7% +$8.65M 9.34% 2
2022
Q4
$124M Buy
3,490,457
+551,387
+19% +$19.6M 10.84% 1
2022
Q3
$87.3M Buy
2,939,070
+1,344,949
+84% +$39.9M 7.56% 2
2022
Q2
$69.9M Buy
1,594,121
+334,959
+27% +$14.7M 4.97% 4
2022
Q1
$55.5M Buy
1,259,162
+691,957
+122% +$30.5M 4.26% 4
2021
Q4
$25M Buy
567,205
+165,551
+41% +$7.31M 1.6% 14
2021
Q3
$15.4M Buy
401,654
+288,975
+256% +$11.1M 1.07% 24
2021
Q2
$4.61M Sell
112,679
-739,527
-87% -$30.3M 0.31% 39
2021
Q1
$31.1M Sell
852,206
-94,375
-10% -$3.44M 2.33% 14
2020
Q4
$35.2M Buy
946,581
+882,209
+1,370% +$32.8M 4.13% 8
2020
Q3
$2.45M Sell
64,372
-162,891
-72% -$6.21M 0.55% 32
2020
Q2
$9.27M Sell
227,263
-283,308
-55% -$11.6M 1.27% 19
2020
Q1
$19.9M Sell
510,571
-512,514
-50% -$19.9M 4.94% 7
2019
Q4
$48.6M Buy
1,023,085
+40,000
+4% +$1.9M 8.58% 1
2019
Q3
$42.3M Buy
983,085
+289,400
+42% +$12.5M 13.13% 1
2019
Q2
$28.1M Sell
693,685
-109,500
-14% -$4.43M 7.87% 3
2019
Q1
$34.1M Buy
803,185
+273,701
+52% +$11.6M 9.94% 2
2018
Q4
$20.4M Buy
529,484
+240,200
+83% +$9.25M 11.04% 2
2018
Q3
$11.7M Buy
289,284
+36,700
+15% +$1.49M 5.15% 5
2018
Q2
$10.3M Buy
252,584
+26,000
+11% +$1.06M 4.72% 5
2018
Q1
$8.95M Buy
+226,584
New +$8.95M 4.16% 8